NCT03503292View on ClinicalTrials.gov

Pharmacogenomics and Post-Operative Nausea and Vomiting

PHASE4CompletedINTERVENTIONAL

Enrollment

92

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions

Postoperative Nausea

Interventions

DRUG

Granisetron

Rapid metabolizer will receive 1mg IV Granisetron

DRUG

Ondansetron

Poor or normal metabolizers will receive 4mg Ondansetron IV

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER